↓ Skip to main content

Dove Medical Press

Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, September 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
30 Mendeley
Title
Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico
Published in
ClinicoEconomics and Outcomes Research: CEOR, September 2018
DOI 10.2147/ceor.s157642
Pubmed ID
Authors

Rayo Morfín-Otero, Martha Alvarado-Ibarra, Eduardo Rodriguez-Noriega, Jesus Resendiz-Sanchez, Dipen A Patel, Jennifer M Stephens, Manuela Di Fusco, Carlos F Mendoza, Claudie Charbonneau

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 4 13%
Student > Bachelor 3 10%
Other 2 7%
Student > Master 2 7%
Researcher 2 7%
Other 2 7%
Unknown 15 50%
Readers by discipline Count As %
Medicine and Dentistry 7 23%
Nursing and Health Professions 2 7%
Social Sciences 2 7%
Economics, Econometrics and Finance 2 7%
Business, Management and Accounting 1 3%
Other 3 10%
Unknown 13 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2018.
All research outputs
#15,151,839
of 25,461,852 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#273
of 525 outputs
Outputs of similar age
#181,196
of 345,970 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#7
of 14 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,970 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.